Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 841–900 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
… all patients. There were no adverse events associated with the anifrolumab treatment.Abstract PO:11:288 Table 1Baseline characteristics of…
…ation 10.9 years were included. The main reasons for initiating anifrolumab were cutaneous manifestations in 5 patients (41.7%), articular …
…b8a, or Rab11, or treatment with the pharmacological inhibitors Bafilomycin A1, chloroquine (CQ), or 3-MA, significantly reduced release of BA…
…7 Figure 1Conclusions Digital-BILAG allows rapid application of BILAG-2004 within clinic appointments with minimal training: it accelerate…
…ndard oral therapy with rifampicin, isoniazid, pyrazinamide and ethambutol, achieving full recovery. This case highlights the value of sho…
…curacy.Conclusion The TURPAID score did not effectively predict colchicine resistance in the JIR cohort. Its limited generalisability may …
…inuation because of its correlation with the cumulative dose of oxaliplatin. Currently, effective preventive measures are unavailable. Howe…
…were compared with MITT (salmeterol/fluticasone propionate with tiotropium (SAL/FP+TIO). A comprehensive literature review was performed t…
…79.2) ng/mL, p<0.001) compared with HCs (25 (21.6–31.1) ng/mL). S100A8 showed good diagnostic accuracy for APS (area under the curve (…
…mmunoregulatory subset enriched in HBV-ACLF, and their product, Resistin, exerts significant hepatoprotective and anti-inflammatory effe…
…) occurred equally in the non-methadone group compared with the methadone group. The percentage of intraoperative time spent above thresh…
…oring antitumor immunity and re-sensitizing resistant tumors to sotorasib treatment.Conclusions These results identify the PD-L1-driven i…